JP2021516991A5 - - Google Patents
Info
- Publication number
- JP2021516991A5 JP2021516991A5 JP2020568945A JP2020568945A JP2021516991A5 JP 2021516991 A5 JP2021516991 A5 JP 2021516991A5 JP 2020568945 A JP2020568945 A JP 2020568945A JP 2020568945 A JP2020568945 A JP 2020568945A JP 2021516991 A5 JP2021516991 A5 JP 2021516991A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- amino acid
- composition
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023222587A JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Ｃｐｇアンフィフィル及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637824P | 2018-03-02 | 2018-03-02 | |
| US62/637,824 | 2018-03-02 | ||
| PCT/US2019/020398 WO2019169328A1 (en) | 2018-03-02 | 2019-03-01 | Cpg amphiphiles and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023222587A Division JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Ｃｐｇアンフィフィル及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021516991A JP2021516991A (ja) | 2021-07-15 |
| JP2021516991A5 true JP2021516991A5 (enExample) | 2022-03-09 |
Family
ID=67805576
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568945A Pending JP2021516991A (ja) | 2018-03-02 | 2019-03-01 | Ｃｐｇアンフィフィル及びその使用 |
| JP2023222587A Pending JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Ｃｐｇアンフィフィル及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023222587A Pending JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Ｃｐｇアンフィフィル及びその使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US12247052B2 (enExample) |
| EP (1) | EP3758712B1 (enExample) |
| JP (2) | JP2021516991A (enExample) |
| KR (2) | KR102837422B1 (enExample) |
| CN (2) | CN112203663A (enExample) |
| AU (1) | AU2019227988B2 (enExample) |
| BR (1) | BR112020017778A2 (enExample) |
| CA (1) | CA3092693A1 (enExample) |
| DK (1) | DK3758712T3 (enExample) |
| ES (1) | ES3035198T3 (enExample) |
| IL (1) | IL277101B2 (enExample) |
| MA (1) | MA52434A (enExample) |
| MX (1) | MX2020009150A (enExample) |
| MY (1) | MY209484A (enExample) |
| PL (1) | PL3758712T3 (enExample) |
| PT (1) | PT3758712T (enExample) |
| SA (1) | SA520420065B1 (enExample) |
| SG (1) | SG11202008432XA (enExample) |
| UA (1) | UA128863C2 (enExample) |
| WO (1) | WO2019169328A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11696954B2 (en) | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| JP7419268B2 (ja) | 2018-03-02 | 2024-01-22 | エリシオ セラピューティクス， インク． | 変異ｋｒａｓ配列及び脂質を含む化合物並びにその使用 |
| CA3183735A1 (en) * | 2020-06-26 | 2021-12-30 | Martin P. STEINBUCK | Compositions and methods for inducing an immune response against coronavirus |
| CN116507344A (zh) * | 2020-06-26 | 2023-07-28 | 伊莱西奥治疗有限公司 | 用于诱导针对冠状病毒的免疫应答的组合物和方法 |
| AU2022329730A1 (en) * | 2021-08-16 | 2024-03-14 | Elicio Therapeutics, Inc. | Compositions containing polynucleotide amphiphiles and methods of use thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6168778B1 (en) * | 1990-06-11 | 2001-01-02 | Nexstar Pharmaceuticals, Inc. | Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes |
| PT2281843T (pt) | 2000-06-16 | 2017-01-02 | Human Genome Sciences Inc | Anticorpos que se ligam imunoespecificamente a blys |
| US8771702B2 (en) * | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| WO2005001116A1 (ja) * | 2003-06-17 | 2005-01-06 | Meiji Dairies Corporation | Toll様レセプター強制発現細胞の利用 |
| US9090673B2 (en) | 2003-12-12 | 2015-07-28 | City Of Hope | Synthetic conjugate of CpG DNA and T-help/CTL peptide |
| EP1776105A2 (en) * | 2004-07-18 | 2007-04-25 | Coley Pharmaceutical Group, Ltd | Methods and compositions for inducing innate immune responses |
| PT2078080E (pt) | 2006-09-27 | 2015-09-18 | Coley Pharm Gmbh | Análogos dos oligonucleotídeos cpg que contêm análogos t hidrofóbicos com atividade imunoestimulante potenciada |
| WO2008147956A2 (en) * | 2007-05-25 | 2008-12-04 | Centocor, Inc. | Toll-like receptor 3 modulators and uses thereof |
| WO2010071852A2 (en) * | 2008-12-19 | 2010-06-24 | University Of Florida Research Foundation, Inc. | Oligonucleotide micelles |
| CN110542754A (zh) | 2009-05-19 | 2019-12-06 | 迈阿密大学 | 用于体外抗原呈递、评估疫苗功效及生物制剂和药物的免疫毒性的组合物、试剂盒和方法 |
| WO2011036557A1 (en) * | 2009-09-22 | 2011-03-31 | The University Of British Columbia | Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles |
| DK2547355T3 (en) | 2010-03-19 | 2017-03-20 | Baxalta GmbH | TFPI INHIBITORS AND METHODS OF USE |
| US20120328701A1 (en) * | 2011-01-24 | 2012-12-27 | Anterios, Inc. | Nanoparticle compositions, formulations thereof, and uses therefor |
| CN103702662B (zh) | 2011-05-25 | 2018-07-20 | 卡穆鲁斯公司 | 控制释放肽制剂 |
| CN103958542A (zh) | 2011-09-23 | 2014-07-30 | 抗菌技术,生物技术研究与发展股份有限公司 | 经修饰的白蛋白结合结构域及其用于改善药代动力学的用途 |
| WO2014063155A1 (en) | 2012-10-21 | 2014-04-24 | University Of Rochester | Thy1 (cd90) as a novel therapy to control adipose tissue accumulation |
| KR102109188B1 (ko) | 2013-04-01 | 2020-05-11 | 삼성전자주식회사 | 양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도 |
| AR095882A1 (es) | 2013-04-22 | 2015-11-18 | Hoffmann La Roche | Terapia de combinación de anticuerpos contra csf-1r humano con un agonista de tlr9 |
| EP3061547B1 (en) * | 2013-10-24 | 2019-12-04 | Daicel Corporation | Method for producing dispersion liquid containing silver nanoparticles, and dispersion liquid containing silver nanoparticles |
| US20170246288A1 (en) * | 2014-09-11 | 2017-08-31 | Vedantra Pharmaceuticals, Inc. | Multilamellar lipid vesicle compositions and methods of use |
| US10940201B2 (en) * | 2015-09-30 | 2021-03-09 | Shionogi & Co., Ltd. | Nucleic acid derivative having immunostimulatory activity |
| CA3035591A1 (en) | 2016-11-30 | 2018-06-07 | Advaxis, Inc. | Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof |
| WO2018154010A1 (en) * | 2017-02-23 | 2018-08-30 | Alpha-O Peptides Ag | Self-assembling protein nanoparticles encapsulating immunostimulatory nucleid acids |
| JP7419268B2 (ja) * | 2018-03-02 | 2024-01-22 | エリシオ セラピューティクス， インク． | 変異ｋｒａｓ配列及び脂質を含む化合物並びにその使用 |
-
2019
- 2019-03-01 MA MA052434A patent/MA52434A/fr unknown
- 2019-03-01 KR KR1020207028281A patent/KR102837422B1/ko active Active
- 2019-03-01 PT PT197613847T patent/PT3758712T/pt unknown
- 2019-03-01 BR BR112020017778-4A patent/BR112020017778A2/pt unknown
- 2019-03-01 EP EP19761384.7A patent/EP3758712B1/en active Active
- 2019-03-01 ES ES19761384T patent/ES3035198T3/es active Active
- 2019-03-01 UA UAA202006353A patent/UA128863C2/uk unknown
- 2019-03-01 IL IL277101A patent/IL277101B2/en unknown
- 2019-03-01 US US16/977,185 patent/US12247052B2/en active Active
- 2019-03-01 MX MX2020009150A patent/MX2020009150A/es unknown
- 2019-03-01 WO PCT/US2019/020398 patent/WO2019169328A1/en not_active Ceased
- 2019-03-01 CA CA3092693A patent/CA3092693A1/en active Pending
- 2019-03-01 PL PL19761384.7T patent/PL3758712T3/pl unknown
- 2019-03-01 MY MYPI2020004499A patent/MY209484A/en unknown
- 2019-03-01 KR KR1020257023614A patent/KR20250111403A/ko active Pending
- 2019-03-01 JP JP2020568945A patent/JP2021516991A/ja active Pending
- 2019-03-01 CN CN201980028828.9A patent/CN112203663A/zh active Pending
- 2019-03-01 CN CN202510413325.0A patent/CN120249290A/zh active Pending
- 2019-03-01 DK DK19761384.7T patent/DK3758712T3/da active
- 2019-03-01 AU AU2019227988A patent/AU2019227988B2/en active Active
- 2019-03-01 SG SG11202008432XA patent/SG11202008432XA/en unknown
-
2020
- 2020-08-31 SA SA520420065A patent/SA520420065B1/ar unknown
-
2023
- 2023-12-28 JP JP2023222587A patent/JP2024045151A/ja active Pending
-
2025
- 2025-01-31 US US19/042,771 patent/US20250171507A1/en not_active Abandoned
- 2025-09-19 US US19/333,784 patent/US20260015390A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516991A5 (enExample) | ||
| JP7504464B2 (ja) | 核酸ワクチン | |
| JP7330590B2 (ja) | 水痘帯状疱疹ウイルス（ｖｚｖ）のための核酸ワクチン | |
| JP2021519595A (ja) | 新規ｒｓｖ ｒｎａ分子及びワクチン接種用組成物 | |
| JP2013532971A5 (enExample) | ||
| KR20180096591A (ko) | 광범위 인플루엔자 바이러스 백신 | |
| JP2024045151A (ja) | Ｃｐｇアンフィフィル及びその使用 | |
| JP2015529678A5 (enExample) | ||
| JP2023532290A5 (enExample) | ||
| JP2010530362A5 (enExample) | ||
| WO2024140767A1 (zh) | 用于预防或治疗hpv感染相关疾病的多核苷酸分子 | |
| JP2022507373A5 (enExample) | ||
| JP2009538836A (ja) | 生物活性の精製ＨｓｐＥ７組成物 | |
| RU2229307C1 (ru) | Композиция рекомбинантных белков, способ получения такой композиции, фармацевтический набор реагентов для иммунотерапии и профилактической вакцинации опухолевых заболеваний аногенитальной сферы, способ иммунотерапии и профилактической вакцинации на его основе | |
| JP2012501351A5 (enExample) | ||
| JP2011504108A5 (enExample) | ||
| RU2823677C2 (ru) | Cpg амфифилы и их применения | |
| WO2025092908A1 (zh) | 治疗HPV感染相关疾病的mRNA疫苗 | |
| CN118021956A (zh) | 一种编码抗禽流感H7N9病毒抗体的mRNA及其制法和应用 | |
| HK40045177B (en) | Cpg amphiphiles and uses thereof | |
| HK40045177A (en) | Cpg amphiphiles and uses thereof | |
| HK40043266A (en) | Cpg amphiphiles and uses thereof | |
| Wagner et al. | What is the future of targeted therapy in head and neck cancer? | |
| JP2014503174A5 (enExample) |